Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts.

Litonjua AA, Lasky-Su J, Schneiter K, Tantisira KG, Lazarus R, Klanderman B, Lima JJ, Irvin CG, Peters SP, Hanrahan JP, Liggett SB, Hawkins GA, Meyers DA, Bleecker ER, Lange C, Weiss ST.

Am J Respir Crit Care Med. 2008 Oct 1;178(7):688-94. doi: 10.1164/rccm.200709-1363OC. Epub 2008 Jul 10.

2.

Pharmacogenetics of asthma.

Lima JJ, Blake KV, Tantisira KG, Weiss ST.

Curr Opin Pulm Med. 2009 Jan;15(1):57-62. doi: 10.1097/MCP.0b013e32831da8be. Review.

3.

Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.

Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, Douglas G, Muers M, Smith D, White J.

Health Technol Assess. 2001;5(26):1-149. Review.

4.

Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine.

Ortega VE, Meyers DA.

J Allergy Clin Immunol. 2014 Jan;133(1):16-26. doi: 10.1016/j.jaci.2013.10.040. Review.

5.

Do genetic polymorphisms alter patient response to inhaled bronchodilators?

Lima JJ.

Expert Opin Drug Metab Toxicol. 2014 Sep;10(9):1231-40. doi: 10.1517/17425255.2014.939956. Epub 2014 Aug 7. Review.

PMID:
25102170
6.

Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma.

Travers AH, Jones AP, Camargo CA Jr, Milan SJ, Rowe BH.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD010256. doi: 10.1002/14651858.CD010256. Review.

PMID:
23235686
7.

Anticholinergic therapy for acute asthma in children.

Teoh L, Cates CJ, Hurwitz M, Acworth JP, van Asperen P, Chang AB.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD003797. doi: 10.1002/14651858.CD003797.pub2. Review.

PMID:
22513916
8.

Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid.

Walters EH, Gibson PG, Lasserson TJ, Walters JA.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD001385. Review.

PMID:
17253458
9.

Pharmacogenomics of beta2-agonist: key focus on signaling pathways.

Bhatnagar P, Guleria R, Kukreti R.

Pharmacogenomics. 2006 Sep;7(6):919-33. Review.

PMID:
16981850
10.
11.

Pharmacogenetics of asthma therapy.

Duan QL, Tantisira KG.

Curr Pharm Des. 2009;15(32):3742-53. Review.

PMID:
19925425
12.

Addition of intravenous aminophylline to inhaled beta(2)-agonists in adults with acute asthma.

Nair P, Milan SJ, Rowe BH.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD002742. doi: 10.1002/14651858.CD002742.pub2. Review.

PMID:
23235591
13.

Overview of the pharmacogenetics of asthma treatment.

Weiss ST, Litonjua AA, Lange C, Lazarus R, Liggett SB, Bleecker ER, Tantisira KG.

Pharmacogenomics J. 2006 Sep-Oct;6(5):311-26. Epub 2006 Apr 25. Review.

PMID:
16568148
14.

Long-acting beta 2-agonists. Role in primary care asthma treatment.

D'Urzo AD.

Can Fam Physician. 1997 Oct;43:1773-7. Review.

Supplemental Content

Support Center